Related Experiment Videos
The herpes simplex virus type I DNA polymerase. Polypeptide structure and antigenic domains
1Institut für Virusforschung, Deutsches Krebsforschungszentrum, Heidelberg, Federal Republic of Germany.
European Journal of Biochemistry
|July 1, 1988
Summary
Polyclonal antibodies targeting herpes simplex virus type I (HSV-1) DNA polymerase domains were developed. Antibodies against central and C-terminal regions inhibited enzyme activity, suggesting their role in catalysis and DNA binding.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Herpes simplex virus type I (HSV-1) DNA polymerase is a key viral enzyme.
- Understanding its structure and function is crucial for antiviral drug development.
Purpose of the Study:
- To generate and characterize polyclonal antibodies against specific domains of HSV-1 DNA polymerase.
- To investigate the functional roles of different polypeptide domains in enzyme activity.
Main Methods:
- Generation of polyclonal antibodies against N-terminal, central, and C-terminal domains of HSV-1 DNA polymerase.
- Immunoblot analysis to confirm antibody specificity.
- Enzyme binding and inhibition assays to assess functional impact.
Main Results:
- Antibodies against central and C-terminal domains significantly inhibited HSV-1 DNA polymerase activity (70-90%).
- Antibodies against the N-terminal domain bound the enzyme but did not inhibit activity.
- Antibodies confirmed the enzyme consists of a single 132 kDa polypeptide.
Conclusions:
- The central and C-terminal domains of HSV-1 DNA polymerase are critical for its catalytic activity and DNA-protein interactions.
- The N-terminal domain appears less directly involved in enzymatic function.
- The HSV-1 DNA polymerase is a single polypeptide chain, consistent with gene predictions.